Page 205 - Read Online

Berezin. Vessel Plus 2018;2:22 I http://dx.doi.org/10.20517/2574-1209.2018.23 Page 9 of 10

circulating endothelial cells in peripheral blood. Cytometry A 2012;81:856-64.
54. Fadini GP, Sartore S, Agostini C, Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care
2007;30:1305-13.
55. Ruszkowska-Ciastek B, Sokup A, Leszcz M, Drela E, Stankowska K, Boinska J, Haor B, Ślusarz R, Lisewska B, Gadomska G, Kubica J,
Rość D. The number of circulating endothelial progenitor cells in healthy individuals--effect of some anthropometric and environmental
factors (a pilot study). Adv Med Sci 2015;60:58-63.
56. Kulwas A, Drela E, Jundziłł W, Góralczyk B, Ruszkowska-Ciastek B, Rość D. Circulating endothelial progenitor cells and angiogenic
factors in diabetes complicated diabetic foot and without foot complications. J Diabetes Complications 2015;29:686-90.
57. Nowak WN, Borys S, Kusińska K, Bukowska-Strakova K, Witek P, Koblik T, Józkowicz A, Małecki MT, Dulak J. Number of
circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without
diabetic foot syndrome. J Diabetes Investig 2014;5:99-107.
58. Drela E, Stankowska K, Kulwas A, Rość D. Endothelial progenitor cells in diabetic foot syndrome. Adv Clin Exp Med 2012;21:249-54.
59. Berezin A. Epigenetics in heart failure phenotypes. BBA Clin 2016;6:31-7.
60. Chong AY, Lip GYH, Freestone B, Blann AD. Increased circulating endothelial cells in acute heart failure: comparison with von
Willebrand factor and soluble E-selectin. Eur J Heart Fail 2006;8:167-72.
61. Boos CJ, Lip GYH, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006;48:1538-47.
62. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol
2000;65:215-20.
63. Wang C, Li H, Fu P, Zhang S, Xiu R. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial
infarction. Clin Hemorheol Microcirc 2005;32:287-96.
64. Makin AJ, Blann AD, Chung NAY, Silverman SH, Lip GYH. Assessment of endothelial 1018 damage in atherosclerotic vascular disease
by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004;25:371-6.
65. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction
and unstable angina by demonstration of circulating endothelial cells. Blood 1999;93:2951-8.
66. Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, et al. Heme oxygenase-1 is required
for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. Antioxid Redox Signal
2014;20:1677-92.
67. Yoon C-H, Hur J, Park K-W, Kim J-H, Lee C-S, Oh I-Y, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS.
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the
role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-27.
68. Oh IY, Yoon CH, Hur J, Kim JH, Kim TY, Lee CS, Park KW, Chae IH, Oh BH, Park YB, Kim HS. Involvement of E-selectin in
recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 2007;110:3891-9.
69. Yoon CH, Hur J, Oh IY, Park KW, Kim TY, Shin JH, Kim JH, Lee CS, Chung JK, Park YB, Kim HS. Intercellular adhesion molecule-1
is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006;
26:1066-72.
70. Ling L, Shen Y, Wang K, Jiang C, Fang C, Ferro A, Kang L, Xu B. Worse clinical outcomes in acute myocardial infarction patients with
type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One 2012;7:e50739.
71. Hoenig MR, Bianchi C, Sellke FW. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk,
wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets 2008;9:422-35.
72. Hexum MK, Tian X, Kaufman DS. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
Methods Mol Biol 2011;767:433-47.
73. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS. Mobilized human hematopoietic stem/progenitor cells promote kidney
repair after ischemia/reperfusion injury. Circulation 2010;121:2211-20.
74. Kang L, Chen Q, Wang L, Gao L, Meng K, Chen J, Ferro A, Xu B. Decreased mobilization of endothelial progenitor cells contributes to
impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol 2009;36:e47-56.
75. Li Y, Alatan G, Ge Z, Liu D. Effects of benazepril on functional activity of endothelial progenitor cells from hypertension patients. Clin
Exp Hypertens 2014;36:545-9.
76. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA. The effect of angiotensin-2 receptor blocker valsartan on circulating level of
endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease. Diabetes Metab Syndr 2015;9:305-9.
77. Raptis AE, Markakis KP, Mazioti MC, Ikonomidis I, Maratou EP, Vlahakos DV, Kotsifaki EE, Voumvourakis AN, Tsirogianni AG,
Lambadiari VA, Lekakis JP, Raptis SA, Dimitriadis GD. Effect of aliskiren on circulating endothelial progenitor cells and vascular
function in patients with type 2 diabetes and essential hypertension. Am J Hypertens 2015;28:22-9.
78. Suzuki R, Fukuda N, Katakawa M, Tsunemi A, Tahira Y, Matsumoto T, Ueno T, Soma M. Effects of an angiotensin II receptor blocker
on the impaired function of endothelial progenitor cells in patients with essential hypertension. Am J Hypertens 2014;27:695-701.
79. Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial
cells. J Am Soc Hypertens 2012;6:85-99.
80. Mehta JL, Szwedo J. Circulating endothelial progenitor cells, microparticles and vascular disease. J Hypertens 2010;28:1611-3.
81. Lee CW, Huang PH, Huang SS, Leu HB, Huang CC, Wu TC, Chen JW, Lin SJ. Decreased circulating endothelial progenitor cell levels
and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy. Hypertens Res 2011; 34:999-1003.
82. Lineen JR, Kuliszewski M, Dacouris N, Liao C, Rudenko D, Deva DP, Goldstein M, Leong-Poi H, Wald R, Yan AT, Yuen DA. Early